Roche Scales NVIDIA AI Factories Globally to Accelerate Drug Discovery, Diagnostic Solutions and Manufacturing Breakthroughs

Source: NVIDIA AI Blog

Overview

Setting up AI factories in simulation — decreasing deployment time from months to days — is accelerating the next industrial revolution. Nowhere was that more apparent than at GTC 2026, where Roche announced a global expansion of NVIDIA‑powered AI factories to speed drug discovery, diagnostic solutions, and manufacturing breakthroughs.

Key Areas

• Drug discovery: Leveraging NVIDIA DGX systems and the DSX Air platform, Roche can run high‑throughput molecular simulations and generative AI models, cutting candidate identification cycles from months to weeks.
• Diagnostics: AI‑enhanced imaging and genomics pipelines are being deployed across Roche’s diagnostic labs, enabling faster, more accurate disease detection.
• Manufacturing: Real‑time process optimization using AI reduces batch variability and improves yield, shortening time‑to‑market for biologics.

The collaboration builds on prior successes where NVIDIA’s AI infrastructure helped Roche reduce the time required for protein‑structure prediction and antibody design. By scaling these capabilities globally, Roche aims to create a network of “AI factories” that can be rapidly provisioned for new projects, dramatically shortening the path from concept to clinical trial.